Sign inGet started

LENZ

LENZ Therapeutics, Inc.CIK 1815776 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$9.13M
3 trades · 1 insiders
Net · 90d
$-9.13M
Insiders on file
19

AI insights for LENZ PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for LENZ
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

$9.13M2026-10-29 buys — 2026-10-29 sales $9.13M10-29
■ Open-market buys (P)   ■ Open-market sales (S) · daily dollar value by transaction date

Insiders

InsiderRoleTradesBoughtSoldLast trade
RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner4$0$9.13M2026-10-29
Guerard FredericDirector5$0$02026-06-15
Scheiner ZacharyDirector3$0$02026-06-15
George Jeffrey P.Director4$49.9K$02026-06-15
Drapkin Kimberlee CDirector3$0$02026-06-15
Thunen Shelley BDirector3$0$02026-06-15
MCCOLLUM JAMES WDirector9$740.3K$02026-06-15
Schimmelpennink Evert B.President, CEO and Secretary11$251.4K$02026-03-27
Chevallard Daniel R.Chief Financial Officer8$164.3K$02026-03-27
Odrich MarcChief Medical Officer6$0$02026-01-02
Olsson ShawnChief Commercial Officer15$0$261.0K2026-01-02
Versant Vantage II GP-GP, LLC10% Owner8$0$26.60M2025-09-30
Versant Venture Capital VI, L.P.10% Owner10$0$15.97M2025-09-18
Versant Ventures VII GP, L.P.10% Owner12$0$7.42M2025-08-26
Versant Ventures VII GP-GP, LLC10% Owner1$0$6.51M2025-07-10
Versant Ventures VI GP, L.P.10% Owner3$0$10.11M2025-06-20
RA Capital Healthcare Fund LPDirector, 10% Owner1$0$02025-06-11
Versant Vantage II GP, L.P.10% Owner1$0$02024-03-21
RA Capital Nexus Fund II, L.P.Director, 10% Owner9$15.00M$02024-03-21

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
RA CAPITAL MANAGEMENT, L.P.10% Owner S Sale2026-10-292026-11-02107,170$3.36 $360.1K57,559SEC↗
RA CAPITAL MANAGEMENT, L.P.10% Owner S Sale2026-10-292026-11-02451,998$3.36 $1.52M242,757SEC↗
RA CAPITAL MANAGEMENT, L.P.10% Owner S Sale2026-10-292026-11-022,159,516$3.36 $7.26M1,159,823SEC↗
Scheiner ZacharyDirector A Award deriv2026-06-152026-06-1522,100— $022,100SEC↗
Guerard FredericDirector A Award deriv2026-06-152026-06-1522,100— $022,100SEC↗
Thunen Shelley BDirector A Award deriv2026-06-152026-06-1522,100— $022,100SEC↗
MCCOLLUM JAMES WDirector A Award deriv2026-06-152026-06-1522,100— $022,100SEC↗
Drapkin Kimberlee CDirector A Award deriv2026-06-152026-06-1522,100— $022,100SEC↗
George Jeffrey P.Director A Award deriv2026-06-152026-06-1522,100— $022,100SEC↗
RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner A Award deriv2026-06-152026-06-1522,100— $022,100SEC↗
Chevallard Daniel R.Chief Financial Officer P Buy2026-03-272026-03-307,500$8.57 $64.3K12,886SEC↗
Schimmelpennink Evert B.President, CEO and Secretary P Buy2026-03-272026-03-3028,089$8.95 $251.4K77,289SEC↗
George Jeffrey P.Director P Buy2026-03-272026-03-305,592$8.92 $49.9K5,592SEC↗
Schimmelpennink Evert B.President, CEO and Secretary A Award deriv2026-01-022026-01-06358,100— $0358,100SEC↗
Chevallard Daniel R.Chief Financial Officer A Award deriv2026-01-022026-01-0684,200— $084,200SEC↗
Chevallard Daniel R.Chief Financial Officer A Award deriv2026-01-022026-01-0614,000— $014,000SEC↗
Odrich MarcChief Medical Officer A Award deriv2026-01-022026-01-0684,200— $084,200SEC↗
Odrich MarcChief Medical Officer A Award deriv2026-01-022026-01-0614,000— $014,000SEC↗
Olsson ShawnChief Commercial Officer A Award deriv2026-01-022026-01-0614,000— $014,000SEC↗
Olsson ShawnChief Commercial Officer A Award deriv2026-01-022026-01-0684,200— $084,200SEC↗
Olsson ShawnChief Commercial Officer M Exercise deriv2025-11-172025-11-1910,000— $053,241SEC↗
Olsson ShawnChief Commercial Officer S Sale2025-11-172025-11-195,788$26.37 $152.6K4,733SEC↗
Olsson ShawnChief Commercial Officer S Sale2025-11-172025-11-194,212$25.74 $108.4K10,521SEC↗
Olsson ShawnChief Commercial Officer M Exercise2025-11-172025-11-1910,000$2.08 $20.8K14,733SEC↗
Chevallard Daniel R.Chief Financial Officer P Buy2025-11-072025-11-0720$22.71 $4543,208SEC↗
Chevallard Daniel R.Chief Financial Officer P Buy2025-11-072025-11-072,178$22.76 $49.6K5,386SEC↗
MCCOLLUM JAMES WDirector P Buy2025-11-072025-11-1010,500$22.79 $239.3K10,500SEC↗
Versant Vantage II GP-GP, LLC10% Owner S Sale2025-09-302025-10-02123$47.01 $5.8K764,127SEC↗
Versant Vantage II GP-GP, LLC10% Owner S Sale2025-09-302025-10-02177$47.01 $8.3K1,050,599SEC↗
Versant Vantage II GP-GP, LLC10% Owner S Sale2025-09-302025-10-0257,502$46.41 $2.67M764,250SEC↗
Versant Vantage II GP-GP, LLC10% Owner S Sale2025-09-302025-10-0283,066$46.41 $3.86M1,050,776SEC↗
Versant Vantage II GP-GP, LLC10% Owner S Sale2025-09-302025-10-0249,701$45.35 $2.25M1,133,842SEC↗
Versant Vantage II GP-GP, LLC10% Owner S Sale2025-09-302025-10-0234,405$45.35 $1.56M821,752SEC↗
Versant Venture Capital VI, L.10% Owner S Sale2025-09-182025-09-2240,907$43.00 $1.76M1,183,811SEC↗
Versant Venture Capital VI, L.10% Owner S Sale2025-09-182025-09-22268$43.30 $11.6K1,183,543SEC↗
Versant Venture Capital VI, L.10% Owner S Sale2025-09-182025-09-2220,148$43.00 $866.4K856,289SEC↗
Versant Venture Capital VI, L.10% Owner S Sale2025-09-182025-09-22132$43.30 $5.7K856,157SEC↗
Versant Venture Capital VI, L.10% Owner S Sale2025-09-182025-09-2224,370$41.59 $1.01M876,437SEC↗
Versant Venture Capital VI, L.10% Owner S Sale2025-09-182025-09-2249,479$41.59 $2.06M1,224,718SEC↗
Versant Ventures VII GP, L.P.10% Owner S Sale2025-08-262025-08-2621,661$38.97 $844.1K902,514SEC↗
Versant Ventures VII GP, L.P.10% Owner S Sale2025-08-262025-08-263,465$39.50 $136.9K1,274,197SEC↗
Versant Ventures VII GP, L.P.10% Owner S Sale2025-08-262025-08-261,707$39.50 $67.4K900,807SEC↗
Versant Ventures VII GP, L.P.10% Owner S Sale2025-08-262025-08-2643,978$38.97 $1.71M1,277,662SEC↗
Versant Ventures VII GP, L.P.10% Owner S Sale2025-08-252025-08-262,149$39.92 $85.8K1,321,640SEC↗
Versant Ventures VII GP, L.P.10% Owner S Sale2025-08-252025-08-2624,760$39.53 $978.8K925,233SEC↗
Versant Ventures VII GP, L.P.10% Owner S Sale2025-08-252025-08-2650,270$39.53 $1.99M1,323,789SEC↗
Versant Ventures VII GP, L.P.10% Owner S Sale2025-08-252025-08-261,058$39.92 $42.2K924,175SEC↗
Versant Ventures VII GP, L.P.10% Owner S Sale2025-08-222025-08-2610,076$40.03 $403.3K952,802SEC↗
Versant Ventures VII GP, L.P.10% Owner S Sale2025-08-222025-08-262,809$40.59 $114.0K949,993SEC↗
Versant Ventures VII GP, L.P.10% Owner S Sale2025-08-222025-08-265,668$40.59 $230.1K1,374,059SEC↗
Versant Ventures VII GP, L.P.10% Owner S Sale2025-08-222025-08-2620,493$40.03 $820.3K1,379,727SEC↗
Versant Venture Capital VI, L.10% Owner S Sale2025-08-182025-08-1930,628$38.56 $1.18M1,400,220SEC↗
Versant Venture Capital VI, L.10% Owner S Sale2025-08-182025-08-1915,085$38.56 $581.7K962,878SEC↗
Versant Venture Capital VI, L.10% Owner S Sale2025-08-152025-08-19145,051$39.50 $5.73M1,430,848SEC↗
Versant Venture Capital VI, L.10% Owner S Sale2025-08-152025-08-1969,949$39.50 $2.76M977,963SEC↗
Versant Ventures VII GP-GP, LL10% Owner S Sale2025-07-102025-07-14191,376$34.00 $6.51M1,575,899SEC↗
Versant Vantage II GP-GP, LLC10% Owner S Sale2025-06-272025-07-01200,000$30.47 $6.09M1,767,275SEC↗
Versant Ventures VI GP, L.P.10% Owner S Sale2025-06-202025-06-20133,924$30.25 $4.05M1,967,275SEC↗
Versant Ventures VI GP, L.P.10% Owner S Sale2025-06-202025-06-20100,877$30.35 $3.06M1,047,912SEC↗
Versant Ventures VI GP, L.P.10% Owner S Sale2025-06-182025-06-20100,000$29.95 $3.00M1,148,789SEC↗
Scheiner ZacharyDirector A Award deriv2025-06-112025-06-1113,500— $013,500SEC↗
MCCOLLUM JAMES WDirector A Award deriv2025-06-112025-06-1113,500— $013,500SEC↗
Thunen Shelley BDirector A Award deriv2025-06-112025-06-1113,500— $013,500SEC↗
Guerard FredericDirector A Award deriv2025-06-112025-06-1113,500— $013,500SEC↗
Drapkin Kimberlee CDirector A Award deriv2025-06-112025-06-1113,500— $013,500SEC↗
George Jeffrey P.Director A Award deriv2025-06-112025-06-1113,500— $013,500SEC↗
RA Capital Healthcare Fund LPDirector, 10% Owner A Award deriv2025-06-112025-06-1113,500— $013,500SEC↗
Versant Vantage II GP-GP, LLC10% Owner S Sale2025-06-102025-06-12350,000$29.00 $10.15M1,248,789SEC↗
Olsson ShawnChief Commercial Officer M Exercise deriv2025-04-092025-04-091,400— $063,241SEC↗
Olsson ShawnChief Commercial Officer M Exercise2025-04-092025-04-091,400$2.08 $2.9K4,733SEC↗
Schimmelpennink Evert B.President, CEO and Secretary M Exercise deriv2025-03-072025-03-074,200— $0337,906SEC↗
Schimmelpennink Evert B.President, CEO and Secretary M Exercise2025-03-072025-03-074,200$1.04 $4.4K49,200SEC↗
Schimmelpennink Evert B.President, CEO and Secretary A Award deriv2025-01-092025-01-13279,100— $0279,100SEC↗
Chevallard Daniel R.Chief Financial Officer A Award deriv2025-01-092025-01-1370,444— $070,444SEC↗
Odrich MarcChief Medical Officer A Award deriv2025-01-092025-01-1380,100— $080,100SEC↗
Olsson ShawnChief Commercial Officer A Award deriv2025-01-092025-01-1380,100— $080,100SEC↗
Olsson ShawnChief Commercial Officer M Exercise deriv2024-12-162024-12-173,333— $064,641SEC↗
Olsson ShawnChief Commercial Officer M Exercise2024-12-162024-12-173,333$2.08 $6.9K3,333SEC↗
Schimmelpennink Evert B.President, CEO and Secretary M Exercise deriv2024-07-222024-07-2345,000— $0342,106SEC↗
Schimmelpennink Evert B.President, CEO and Secretary M Exercise2024-07-222024-07-2345,000$1.04 $46.8K45,000SEC↗
Chevallard Daniel R.Chief Financial Officer P Buy2024-05-142024-05-153,188$15.68 $50.0K3,188SEC↗
MCCOLLUM JAMES WDirector P Buy2024-05-132024-05-1431,332$15.99 $501.0K525,565SEC↗
Schimmelpennink Evert B.President, CEO and Secretary A Award deriv2024-03-212024-03-25475,000— $0475,000SEC↗
Schimmelpennink Evert B.President, CEO and Secretary A Award deriv2024-03-212024-03-25387,106— $0387,106SEC↗
Schimmelpennink Evert B.President, CEO and Secretary A Award deriv2024-03-212024-03-2582,723— $082,723SEC↗
Schimmelpennink Evert B.President, CEO and Secretary A Award deriv2024-03-212024-03-25315,864— $0315,864SEC↗
Odrich MarcChief Medical Officer A Award deriv2024-03-212024-03-25105,000— $0105,000SEC↗
Odrich MarcChief Medical Officer A Award deriv2024-03-212024-03-2566,472— $066,472SEC↗
Olsson ShawnChief Commercial Officer A Award deriv2024-03-212024-03-25105,000— $0105,000SEC↗
Olsson ShawnChief Commercial Officer A Award deriv2024-03-212024-03-2550,915— $050,915SEC↗
Olsson ShawnChief Commercial Officer A Award deriv2024-03-212024-03-2530,466— $030,466SEC↗
Olsson ShawnChief Commercial Officer A Award deriv2024-03-212024-03-2567,974— $067,974SEC↗
Chevallard Daniel R.Chief Financial Officer A Award deriv2024-03-212024-03-25200,000— $0200,000SEC↗
George Jeffrey P.Director A Award deriv2024-03-212024-03-2527,000— $027,000SEC↗
Drapkin Kimberlee CDirector A Award deriv2024-03-212024-03-2527,000— $027,000SEC↗
Scheiner ZacharyDirector A Award deriv2024-03-212024-03-2527,000— $027,000SEC↗
Guerard FredericDirector A Award deriv2024-03-212024-03-2523,571— $023,571SEC↗
Guerard FredericDirector A Award deriv2024-03-212024-03-2527,000— $027,000SEC↗
Guerard FredericDirector A Award deriv2024-03-212024-03-2530,897— $030,897SEC↗
MCCOLLUM JAMES WDirector A Award deriv2024-03-212024-03-256,575— $06,575SEC↗
MCCOLLUM JAMES WDirector A Award deriv2024-03-212024-03-2527,000— $027,000SEC↗
Thunen Shelley BDirector A Award deriv2024-03-212024-03-2527,000— $027,000SEC↗
RA Capital Nexus Fund II, L.P.Director, 10% Owner A Award deriv2024-03-212024-03-2510,580— $010,580SEC↗
RA Capital Nexus Fund II, L.P.Director, 10% Owner A Award deriv2024-03-212024-03-255,371— $05,371SEC↗
RA Capital Nexus Fund II, L.P.Director, 10% Owner A Award deriv2024-03-212024-03-2527,000— $027,000SEC↗
RA Capital Nexus Fund II, L.P.Director, 10% Owner A Award deriv2024-03-212024-03-2554,582— $054,582SEC↗
Versant Vantage II GP, L.P.10% Owner J Other2024-03-212024-03-25598,203— $0842,162SEC↗
Odrich MarcChief Medical Officer A Award2024-03-212024-03-2599,599— $099,599SEC↗
MCCOLLUM JAMES WDirector A Award2024-03-212024-03-2516,633$15.03 $250.0K494,233SEC↗
MCCOLLUM JAMES WDirector A Award2024-03-212024-03-25477,600— $0477,600SEC↗
MCCOLLUM JAMES WDirector A Award2024-03-212024-03-2595,034— $095,034SEC↗
RA Capital Nexus Fund II, L.P.Director, 10% Owner A Award2024-03-212024-03-25164,729— $0164,729SEC↗
RA Capital Nexus Fund II, L.P.Director, 10% Owner A Award2024-03-212024-03-25694,755— $0694,755SEC↗
RA Capital Nexus Fund II, L.P.Director, 10% Owner A Award2024-03-212024-03-252,386,301— $02,386,301SEC↗
RA Capital Nexus Fund II, L.P.Director, 10% Owner P Buy2024-03-212024-03-25933,038$15.03 $14.02M3,319,339SEC↗
RA Capital Nexus Fund II, L.P.Director, 10% Owner P Buy2024-03-212024-03-2564,971$15.03 $976.5K694,755SEC↗